Silencing IGF-1R signaling has emerged as a promising strategy against cancer and for overcoming cancer drug resistance, as illustrated by a recent report of the antioxidant molecule vitamin D regulating apoptosis and autophagy and supporting the DNA repair process of cancer cells partly by silencing IGF-1R signaling and its downstream target, β-catenin (14). Here, IGF1R is linked to cancer.